Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Darou Pakhsh Pharmaceutical Manufacturing is one of the largest and most established pharmaceutical companies in Iran, serving as a cornerstone of the country's healthcare infrastructure. Founded in 1956, the company operates extensive manufacturing facilities that produce a diverse range of finished dosage forms, including tablets, capsules, ampoules, vials, and topical products. Its portfolio covers critical therapeutic areas such as cardiovascular health, endocrinology, and infectious diseases, with a significant focus on both generic and branded essential medicines. As a subsidiary of the Darou Pakhsh Holding Company, it plays a vital role in domestic supply and maintains an active export presence in regional markets across Asia and Africa. The company is also recognized for its capabilities in producing specialized treatments, including insulin and various sterile injectable medications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Darou Pakhsh Pharmaceutical Manufacturing.